The purpose of this research study is determining the highest dose of the study drug DT2216 in combination with paclitaxel that can be safely and tolerably adm…

Ovarian CancerOvarian CarcinomaRecurrent Ovary Cancer+1 more

~Estimated

~$10 – $7,500

Elizabeth Stover, MD, PhDNCT06964009

Phase 1

A Phase 1b Study of Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cell Therapy in Recurrent Ovarian Cancer

The goal of this research study is to evaluate the safety and effectiveness of the use of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy …

Platinum-resistant Ovarian CancerRecurrent Ovary CancerOvarian Cancer+4 more

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT06321484